STRATEGY for Left Main Coronary Bifurcation Lesion II
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01798433
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01798433
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01798433. Randomized; no masking; primary purpose treatment. Start 2013-03-18 (actual); primary completion 2018-07-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STRATEGY for Left Main Coronary Bifurcation Lesion II
- Acronym
- STRATEGY-II
- Condition
- Coronary Artery Disease
- Intervention (Device)
- One stent technique alone
- Intervention (Device)
- One stent technique + Elective FKB
- Intervention (Procedure)
- Provisional approach
- Intervention (Device)
- Elective 2-stent
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct01798433- Content hash
5ac2643380f483dae72e841313c79d553cf0a423679c03f174eea8c810cea0f5